Ocular Therapeutix™ Reports Fourth Quarter and Year End 2019 Financial Results and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. IBM

Go back to Ocular Therapeutix™ Reports Fourth Quarter and Year End 2019 Financial Results and Business Update

Ocular Therapeutix (OCUL) Misses Q4 EPS by 8c, Revenues Miss

March 12, 2020 4:39 PM EDT

Ocular Therapeutix (NASDAQ: OCUL) reported Q4 EPS of ($0.53), $0.08 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $2.26 million versus the consensus estimate of $2.54 million.

Ocular Therapeutix has had an impressive final quarter of 2019 and strong start to 2020, said Antony Mattessich,... More